vs

Side-by-side financial comparison of REPLIGEN CORP (RGEN) and VARONIS SYSTEMS INC (VRNS). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $173.1M, roughly 1.1× VARONIS SYSTEMS INC). On growth, VARONIS SYSTEMS INC posted the faster year-over-year revenue change (26.9% vs 13.6%). VARONIS SYSTEMS INC produced more free cash flow last quarter ($49.0M vs $17.6M). Over the past eight quarters, VARONIS SYSTEMS INC's revenue compounded faster (15.2% CAGR vs 14.4%).

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

Varonis Systems, Inc. is a software company based in Miami, Florida with R&D offices in Herzliya, Israel. The company’s Data Security Platform analyzes data and data activity using the insights to identify data exposure risks stemming from access permissions and software-as-a-service (SaaS) app configurations, triggering automated remediation capabilities in response.

RGEN vs VRNS — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.1× larger
RGEN
$197.9M
$173.1M
VRNS
Growing faster (revenue YoY)
VRNS
VRNS
+13.3% gap
VRNS
26.9%
13.6%
RGEN
More free cash flow
VRNS
VRNS
$31.5M more FCF
VRNS
$49.0M
$17.6M
RGEN
Faster 2-yr revenue CAGR
VRNS
VRNS
Annualised
VRNS
15.2%
14.4%
RGEN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
RGEN
RGEN
VRNS
VRNS
Revenue
$197.9M
$173.1M
Net Profit
$13.3M
Gross Margin
52.5%
76.0%
Operating Margin
9.0%
-1.7%
Net Margin
6.7%
Revenue YoY
13.6%
26.9%
Net Profit YoY
143.9%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RGEN
RGEN
VRNS
VRNS
Q1 26
$173.1M
Q4 25
$197.9M
$173.4M
Q3 25
$188.8M
$161.6M
Q2 25
$182.4M
$152.2M
Q1 25
$169.2M
$136.4M
Q4 24
$174.1M
$158.5M
Q3 24
$154.9M
$148.1M
Q2 24
$154.1M
$130.3M
Net Profit
RGEN
RGEN
VRNS
VRNS
Q1 26
Q4 25
$13.3M
$-27.8M
Q3 25
$14.9M
$-29.9M
Q2 25
$14.9M
$-35.8M
Q1 25
$5.8M
$-35.8M
Q4 24
$-30.3M
$-13.0M
Q3 24
$-654.0K
$-18.3M
Q2 24
$3.3M
$-23.9M
Gross Margin
RGEN
RGEN
VRNS
VRNS
Q1 26
76.0%
Q4 25
52.5%
78.9%
Q3 25
53.2%
78.2%
Q2 25
50.0%
79.5%
Q1 25
53.6%
78.7%
Q4 24
26.1%
83.6%
Q3 24
50.0%
83.8%
Q2 24
49.8%
82.8%
Operating Margin
RGEN
RGEN
VRNS
VRNS
Q1 26
-1.7%
Q4 25
9.0%
-17.5%
Q3 25
8.9%
-22.2%
Q2 25
7.6%
-24.0%
Q1 25
3.9%
-32.1%
Q4 24
-17.7%
-11.1%
Q3 24
-5.1%
-16.0%
Q2 24
1.0%
-22.1%
Net Margin
RGEN
RGEN
VRNS
VRNS
Q1 26
Q4 25
6.7%
-16.0%
Q3 25
7.9%
-18.5%
Q2 25
8.2%
-23.5%
Q1 25
3.4%
-26.2%
Q4 24
-17.4%
-8.2%
Q3 24
-0.4%
-12.4%
Q2 24
2.2%
-18.4%
EPS (diluted)
RGEN
RGEN
VRNS
VRNS
Q1 26
Q4 25
$0.24
$-0.23
Q3 25
$0.26
$-0.26
Q2 25
$0.26
$-0.32
Q1 25
$0.10
$-0.32
Q4 24
$-0.55
$-0.12
Q3 24
$-0.01
$-0.16
Q2 24
$0.06
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RGEN
RGEN
VRNS
VRNS
Cash + ST InvestmentsLiquidity on hand
$767.6M
$179.3M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$2.1B
$453.5M
Total Assets
$2.9B
$1.6B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RGEN
RGEN
VRNS
VRNS
Q1 26
$179.3M
Q4 25
$767.6M
$883.7M
Q3 25
$748.7M
$671.3M
Q2 25
$708.9M
$770.9M
Q1 25
$697.2M
$567.6M
Q4 24
$757.4M
$529.0M
Q3 24
$784.0M
$844.8M
Q2 24
$809.1M
$582.5M
Total Debt
RGEN
RGEN
VRNS
VRNS
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
RGEN
RGEN
VRNS
VRNS
Q1 26
$453.5M
Q4 25
$2.1B
$598.7M
Q3 25
$2.1B
$604.8M
Q2 25
$2.1B
$341.5M
Q1 25
$2.0B
$367.7M
Q4 24
$2.0B
$455.7M
Q3 24
$2.0B
$428.6M
Q2 24
$2.0B
$458.6M
Total Assets
RGEN
RGEN
VRNS
VRNS
Q1 26
$1.6B
Q4 25
$2.9B
$1.8B
Q3 25
$2.9B
$1.7B
Q2 25
$2.9B
$1.6B
Q1 25
$2.9B
$1.6B
Q4 24
$2.8B
$1.7B
Q3 24
$2.8B
$1.5B
Q2 24
$2.9B
$1.1B
Debt / Equity
RGEN
RGEN
VRNS
VRNS
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RGEN
RGEN
VRNS
VRNS
Operating Cash FlowLast quarter
$25.7M
$55.0M
Free Cash FlowOCF − Capex
$17.6M
$49.0M
FCF MarginFCF / Revenue
8.9%
28.3%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M
$118.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RGEN
RGEN
VRNS
VRNS
Q1 26
$55.0M
Q4 25
$25.7M
$24.7M
Q3 25
$48.1M
$33.4M
Q2 25
$28.6M
$21.3M
Q1 25
$15.0M
$68.0M
Q4 24
$39.2M
$24.3M
Q3 24
$49.3M
$22.5M
Q2 24
$42.2M
$11.7M
Free Cash Flow
RGEN
RGEN
VRNS
VRNS
Q1 26
$49.0M
Q4 25
$17.6M
$20.7M
Q3 25
$43.4M
$30.4M
Q2 25
$21.5M
$18.0M
Q1 25
$11.4M
$65.7M
Q4 24
$33.6M
$19.9M
Q3 24
$42.3M
$21.3M
Q2 24
$37.4M
$10.9M
FCF Margin
RGEN
RGEN
VRNS
VRNS
Q1 26
28.3%
Q4 25
8.9%
12.0%
Q3 25
23.0%
18.8%
Q2 25
11.8%
11.8%
Q1 25
6.8%
48.1%
Q4 24
19.3%
12.6%
Q3 24
27.3%
14.4%
Q2 24
24.3%
8.4%
Capex Intensity
RGEN
RGEN
VRNS
VRNS
Q1 26
Q4 25
4.1%
2.3%
Q3 25
2.5%
1.8%
Q2 25
3.9%
2.2%
Q1 25
2.1%
1.7%
Q4 24
3.2%
2.7%
Q3 24
4.5%
0.8%
Q2 24
3.1%
0.6%
Cash Conversion
RGEN
RGEN
VRNS
VRNS
Q1 26
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RGEN
RGEN

Segment breakdown not available.

VRNS
VRNS

SaaS$161.1M93%
Term license subscriptions$6.9M4%
Maintenance and services$5.2M3%

Related Comparisons